tiprankstipranks
Trending News
More News >
Immunitybio Inc (IBRX)
:IBRX

ImmunityBio (IBRX) Revenue

Compare
1,456 Followers

ImmunityBio Revenue

ImmunityBio had a revenue of 16.52M in the quarter ending Mar 31, 2025, with 118.71%. This bring the company's revenue in the last twelve months to 31.22M, Decreased 111.75%. In the fiscal year ending Dec 31, 2024, ImmunityBio had annual revenue of 14.74M with 2270.58% growth.
Revenue (ttm)
31.22M
Revenue Growth
10238.41%
P/S Ratio
162.82
Revenue/Employee
$21,975
Employees
671
Market Cap
$2.40B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
14.74M14.12M+2,270.58%
Dec 31, 2023
622.00K382.00K+159.17%
Dec 31, 2022
240.00K-694.00K-74.30%
Dec 31, 2021
934.00K329.00K+54.38%
Dec 31, 2020
605.00K-1.60M-72.52%
Dec 31, 2019
2.20M2.15M+4,585.11%
Dec 31, 2018
47.00K2.00K+4.44%
Dec 31, 2017
45.00K1.00K+2.27%
Dec 31, 2016
44.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis